Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

Many coronary stents 'more dangerous than useful’ | A close look at AGENT IDE | Using headphones to monitor heart health

News You Need to Know Today
Many coronary stents 'more dangerous than useful’ | A close look at AGENT IDE | Using headphones to monitor heart health
Wednesday, November 1, 2023
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

‘More dangerous than useful’: 1 in 5 coronary stents implanted by cardiologists are unnecessary, wasting $800M per year

A cardiologist-led think tank tracked data from more than 1 million procedures, exploring the clinical and economic impacts of implanting low-value coronary stents. 

READ MORE >
Patients receive unnecessary coronary stents during percutaneous coronary intervention (PCI) procedures at an alarming rate, according to a new report from the Lown Institute. The analysis included approximately 1 million stent procedures performed at more than 1,700 U.S. hospitals and outpatient facilities from 2019 to 2021.
Share on Twitter Share on Facebook Share on Linkedin

‘More dangerous than useful’: 1 in 5 coronary stents implanted by cardiologists are unnecessary, wasting $800M per year

Share on Twitter Share on Facebook Share on Linkedin
Patients receive unnecessary coronary stents during percutaneous coronary intervention (PCI) procedures at an alarming rate, according to a new report from the Lown Institute. The analysis included approximately 1 million stent procedures performed at more than 1,700 U.S. hospitals and outpatient facilities from 2019 to 2021.
A cardiologist-led think tank tracked data from more than 1 million procedures, exploring the clinical and economic impacts of implanting low-value coronary stents. 
READ MORE >

Coronary drug-coated balloon superior to standard of care for in-stent restenosis

Robert Yeh, MD, detailed the importance of the pivotal AGENT IDE trial, which focused on the use of a paclitaxel-coated balloon to treat in-stent restenosis. 

READ MORE >
Robert Yeh, MD, explains the details of the AGENT IDE trial clinical trial results for the Agent drug-coated balloon vs plain angioplasty for in-stent restenosis at TCT 2023. #TCT #TCT2023 #DCB
Share on Twitter Share on Facebook Share on Linkedin

Coronary drug-coated balloon superior to standard of care for in-stent restenosis

Share on Twitter Share on Facebook Share on Linkedin
Robert Yeh, MD, explains the details of the AGENT IDE trial clinical trial results for the Agent drug-coated balloon vs plain angioplasty for in-stent restenosis at TCT 2023. #TCT #TCT2023 #DCB
Robert Yeh, MD, detailed the importance of the pivotal AGENT IDE trial, which focused on the use of a paclitaxel-coated balloon to treat in-stent restenosis. 
READ MORE >

Google researchers use noise-canceling headphones to monitor heart health

The new technique, audioplethysmography, can monitor a user’s heart rate and other physiological signals using headphones equipped with active noice canceling technology. It requires no additional sensors.

READ MORE >
Image and caption courtesy of Google. APG sends a low intensity ultrasound transmitting wave (TX wave) using an ANC headphone's speakers and collects the receiving wave (RX wave) via the on-board feedback microphones. The APG signal is a pulse-like waveform that synchronizes with heartbeat and reveals rich cardiac information. Audioplethysmography Google headphones.
Share on Twitter Share on Facebook Share on Linkedin

Google researchers use noise-canceling headphones to monitor heart health

Share on Twitter Share on Facebook Share on Linkedin
Image and caption courtesy of Google. APG sends a low intensity ultrasound transmitting wave (TX wave) using an ANC headphone's speakers and collects the receiving wave (RX wave) via the on-board feedback microphones. The APG signal is a pulse-like waveform that synchronizes with heartbeat and reveals rich cardiac information. Audioplethysmography Google headphones.
The new technique, audioplethysmography, can monitor a user’s heart rate and other physiological signals using headphones equipped with active noice canceling technology. It requires no additional sensors.
READ MORE >

Featured Articles

TAVR triumphs over surgery: Exploring 4-year data from the Evolut Low Risk trial

Michael Reardon, MD, discussed his team's late-breaking results at TCT 2023 in San Francisco. 

READ MORE >
Video of Michael Reardon, MD, explaining details from the Evolute Low Risk 4-year results at TCT 2023.
Share on Twitter Share on Facebook Share on Linkedin

TAVR triumphs over surgery: Exploring 4-year data from the Evolut Low Risk trial

Share on Twitter Share on Facebook Share on Linkedin
Video of Michael Reardon, MD, explaining details from the Evolute Low Risk 4-year results at TCT 2023.
Michael Reardon, MD, discussed his team's late-breaking results at TCT 2023 in San Francisco. 
READ MORE >

Portfolio diet—which focuses on plant-based, cholesterol-lowering foods—reduces risk of heart disease and stroke

While it is not as well-known as some other heart-healthy diets, the portfolio diet is linked to key cardiovascular benefits. "We need to get the word out," one dietitian said. 

READ MORE >
Regularly eating avocados is associated with a reduced risk of cardiovascular disease, according to a new study.
Share on Twitter Share on Facebook Share on Linkedin

Portfolio diet—which focuses on plant-based, cholesterol-lowering foods—reduces risk of heart disease and stroke

Share on Twitter Share on Facebook Share on Linkedin
Regularly eating avocados is associated with a reduced risk of cardiovascular disease, according to a new study.
While it is not as well-known as some other heart-healthy diets, the portfolio diet is linked to key cardiovascular benefits. "We need to get the word out," one dietitian said. 
READ MORE >

Holding company acquires heart monitoring specialists Digital Diagnostics Imaging for $11M

DDI currently has contracts with nursing homes and hospitals in 42 states.

READ MORE >
money business cash flow dollar. Kingsway Financial Services, a Chicago-based holding company with subsidiaries in several industries, has acquired New Jersey-based Digital Diagnostics Imaging (DDI) for $11 million. The transaction was funded with $5.4 million in cash and $5.6 million in debt financing.
Share on Twitter Share on Facebook Share on Linkedin

Holding company acquires heart monitoring specialists Digital Diagnostics Imaging for $11M

Share on Twitter Share on Facebook Share on Linkedin
money business cash flow dollar. Kingsway Financial Services, a Chicago-based holding company with subsidiaries in several industries, has acquired New Jersey-based Digital Diagnostics Imaging (DDI) for $11 million. The transaction was funded with $5.4 million in cash and $5.6 million in debt financing.
DDI currently has contracts with nursing homes and hospitals in 42 states.
READ MORE >

In Case You Missed It

Edwards gains CE mark approval for new tricuspid valve replacement device

The approval represents a significant moment in the treatment of structural heart disease. Edwards will share updated data on the device at TCT 2023 in San Francisco.  

READ MORE >
Edwards Lifesciences gained European CE mark approval for Evoque transcatheter tricuspid valve replacement (TTVR) system.
Share on Twitter Share on Facebook Share on Linkedin

Edwards gains CE mark approval for new tricuspid valve replacement device

Share on Twitter Share on Facebook Share on Linkedin
Edwards Lifesciences gained European CE mark approval for Evoque transcatheter tricuspid valve replacement (TTVR) system.
The approval represents a significant moment in the treatment of structural heart disease. Edwards will share updated data on the device at TCT 2023 in San Francisco.  
READ MORE >

Cardiologist-founded virtual cardiology clinic raises $8M to expand heart failure offerings

The company hopes this new round of funding from private-equity investors will help its home-based care model flourish and reach more patients than ever before. 

READ MORE >
Telehealth can provide significant value when it comes to managing and monitoring patients with CVD or suspected CVD. A new scientific statement from the American Heart Association explores the latest details on this evolving treatment option. 
Share on Twitter Share on Facebook Share on Linkedin

Cardiologist-founded virtual cardiology clinic raises $8M to expand heart failure offerings

Share on Twitter Share on Facebook Share on Linkedin
Telehealth can provide significant value when it comes to managing and monitoring patients with CVD or suspected CVD. A new scientific statement from the American Heart Association explores the latest details on this evolving treatment option. 
The company hopes this new round of funding from private-equity investors will help its home-based care model flourish and reach more patients than ever before. 
READ MORE >

In Other News

Nurses weigh in on best and worst hospitals to work for

A new national index showing levels of job satisfaction among nurses has Michigan Medicine and Houston Methodist tied for the top spot overall, at least within the “hospitals and health systems” subcategory.  

READ MORE >
nurse job satisfaction
Share on Twitter Share on Facebook Share on Linkedin

Nurses weigh in on best and worst hospitals to work for

Share on Twitter Share on Facebook Share on Linkedin
nurse job satisfaction
A new national index showing levels of job satisfaction among nurses has Michigan Medicine and Houston Methodist tied for the top spot overall, at least within the “hospitals and health systems” subcategory.  
READ MORE >

Responding to criticism from radiologists, feds aim to fix dispute resolution under No Surprises Act

The rule seeks to improve communication between health insurers, physicians and the independent entities that arbitrate disagreements over out-of-network payments. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Responding to criticism from radiologists, feds aim to fix dispute resolution under No Surprises Act

Share on Twitter Share on Facebook Share on Linkedin
The rule seeks to improve communication between health insurers, physicians and the independent entities that arbitrate disagreements over out-of-network payments. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI company founded by cardiologist makes big splash | Getting clinicians on the same page | Kidney injuries after PCI
Sweeping TAVR changes on the way | Pushing back against AI-powered prior authorization | FDA highlights recall after injuries
Cardiologists added to payment model by mistake | Sex-specific outcomes after TAVR & SAVR | FDA clears new AI software
Private equity unlikely to dominate cardiology | Cardiology opposes Medicare AI prior authorization | New AATS leaders
The real impact of RVU cuts in electrophysiology | TAVR changes on the way | Cardiology groups celebrate bill | BP drug recalled
Blood may leak out of Impella introducers | Leadless conduction and Bachmann's pacing | US study for microvascular disease
Top 10 most popular cardiology video interviews this past month

Pagination

    • Current page 1
    • Page 2
    • Page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup